Proposed: Trial of Vitamin Derivative to Prevent Melanoma

The vitamin B3 derivative nicotinamide was previously shown to reduce nonmelanoma skin cancers in a phase 3 trial.
Medscape Medical News

http://ift.tt/2vDTtlS